FDA Panel Review of GRAIL’s Galleri Multi-Cancer Early Detection Test
The U.S. Food and Drug Administration (FDA) will convene the Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee on September 23, 2026, from 9:00 AM to 6:00 […]